Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Injecting platelet-rich plasma or applying it with a laser or microneedling can treat hair loss effectively. The laser and microneedling methods cause less pain.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

The document explains various skin conditions and their treatments.

Endocrine disorders can cause various skin and hair issues.

Doctors should watch for and treat hormonal issues in obese patients beyond just diabetes.

The document concludes that alopecia has various forms, each with specific treatments, but no definitive cure for certain types like CCCA has been proven.

Terbinafine can cause hair loss.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Targeted cancer therapies often cause serious skin problems that need careful management.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Finasteride with oral contraceptive helps improve hair loss in premenopausal women.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Spironolactone most effective for hirsutism, but has side effects.

Minoxidil and finasteride are effective for male hair loss, minoxidil for female hair loss, and various treatments like corticosteroids work for alopecia areata; treatment should be tailored to the individual.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Lithium therapy may cause skin problems like hidradenitis suppurativa and other side effects, which can improve after stopping the medication.